RE:RE:RE:RE:Biotech industry readies for " Pharma M&A Spree" "Rising tides lift all ships" ... The stock markets are currently at historical highs, and its just a matter of time for certain biotech companies to begin to benefit from this rising tide. ONCY for instance is a late-stage clinical development cancer company that has a cancer drug platform that is aligned with several major Big Pharma product portfolios and future cancer clinical development programs, which is the sort of biotech company that analysts and venture capitalists have identified as being keenly sought by Big Pharma and thus hold premium M&A valuations. . Just sayin ---